These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2852126)
21. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma. Patel YC; Ganda OP; Benoit R J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494 [TBL] [Abstract][Full Text] [Related]
22. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors. Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958 [TBL] [Abstract][Full Text] [Related]
23. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Osei K; O'Dorisio TM Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769 [No Abstract] [Full Text] [Related]
24. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome. von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426 [TBL] [Abstract][Full Text] [Related]
25. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human. Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786 [TBL] [Abstract][Full Text] [Related]
26. A case with glucagonoma syndrome--endocrine and metabolic studies. Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136 [TBL] [Abstract][Full Text] [Related]
27. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies. Soybel D; Jaspan J; Polonsky K; Goldberg I; Rayfield E; Tager H J Clin Endocrinol Metab; 1983 Mar; 56(3):612-8. PubMed ID: 6185527 [TBL] [Abstract][Full Text] [Related]
28. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens. Cieslak SR; Hazelwood RL Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920 [TBL] [Abstract][Full Text] [Related]
30. The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in rat. Jevdjovic T; Maake C; Zwimpfer C; Krey G; Eppler E; Zapf J; Reinecke M Histochem Cell Biol; 2005 Feb; 123(2):179-88. PubMed ID: 15812646 [TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma. Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061 [TBL] [Abstract][Full Text] [Related]
32. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones]. Kawakami K Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):155-70. PubMed ID: 3294051 [TBL] [Abstract][Full Text] [Related]
33. Long-acting somatostatin analog controls acid and gastrin secretion in benign, not in malignant, Zollinger-Ellison syndrome. Bauer FE; Hummel M; Merki HS; Schulz E; Oeder R; Marbach P J Clin Gastroenterol; 1989 Jun; 11(3):282-6. PubMed ID: 2754214 [TBL] [Abstract][Full Text] [Related]
34. Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients. Scheen AJ; Gillet J; Rosenthaler J; Guiot J; Henrivaux P; Jandrain B; Lefèbvre PJ Diabetologia; 1989 Nov; 32(11):801-9. PubMed ID: 2687064 [TBL] [Abstract][Full Text] [Related]
35. Somatostatin inhibition of insulin secretion in insulin-producing tumors. Scuro LA; Lo Cascio V; Adami S; Galvanini G; Bianchi I; Cominacini L; Corgnati A Metabolism; 1976 Jun; 25(6):603-9. PubMed ID: 178978 [No Abstract] [Full Text] [Related]
36. Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes. Vinik AI; Tsai ST; Moattari AR; Cheung P; Eckhauser FE; Cho K Am J Med; 1986 Dec; 81(6B):23-40. PubMed ID: 2879447 [TBL] [Abstract][Full Text] [Related]
37. [Influence of total pancreatectomy on the secretion of human growth hormone and the endocrine pancreas]. Takaesu Y; Nimura Y; Hayakawa N; Yasui K; Ohtsuka K Nihon Geka Gakkai Zasshi; 1988 Oct; 89(10):1686-91. PubMed ID: 3059167 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the changes in plasma human growth hormone (HGH) and immuno-reactive glucagon (IRG) after intravenous and subcutaneous injection of glucagon. Sugase T; Nonaka K; Yoshida T; Morishita S; Toyoshima H; Tarui S; Shima K Endocrinol Jpn; 1976 Jun; 23(3):187-93. PubMed ID: 991830 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory actions of a somatostatin analog SMS 201-995 on endocrine secretion from the isolated perfused stomach and pancreas of the rat. Verchere CB; Kwok YN; Brown JC Pharmacology; 1993; 46(1):50-60. PubMed ID: 8094569 [TBL] [Abstract][Full Text] [Related]
40. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Mukai K; Grotting JC; Greider MH; Rosai J Am J Surg Pathol; 1982 Jul; 6(5):387-99. PubMed ID: 6127037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]